QR Code

Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile

Monica Zolezzi,1 Rawan Abouelhassan,1 Yassin Eltorki,2 Peter M Haddad,2 Mahtab Noorizadeh1 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Mental Health Hospital, Hamad Medical Corporation, Doha, QatarCorrespondence: Monica ZolezziCollege of Pharmacy, Qatar University, PO Box 2713,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zolezzi M, Abouelhassan R, Eltorki Y, Haddad PM, Noorizadeh M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	intramuscular preparations depot antipsychotics injection site adverse effects Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/fe95571e0823467983a83e86dafadb3d
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Recommendation of the Best Site Based on the Distribution Pattern of Extramuscular and Intramusular Nerves for Gluteal Muscle Injection
par: Wu,Junxi, et autres
Publié: (2020)

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
par: Suda A, et autres
Publié: (2018)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
par: Montemagni C, et autres
Publié: (2016)

Pain from intramuscular vaccine injection in adults
par: Sahngun Nahm,Francis, et autres
Publié: (2012)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
par: Sugawara N, et autres
Publié: (2019)

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study
par: Chiu LL, et autres
Publié: (2019)

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
par: Pietrini F, et autres
Publié: (2019)

Discrepancy in Taiwanese psychiatrists’ preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey
par: Liu CH, et autres
Publié: (2018)

Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection
par: Fitzgerald HM, et autres
Publié: (2021)

Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia
par: Ohnishi T, et autres
Publié: (2021)

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1
par: Sajatovic M, et autres
Publié: (2018)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
par: Sajatovic M, et autres
Publié: (2018)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
par: Stephan Hjorth, et autres
Publié: (2021)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
par: Birgit Sadoghi, et autres
Publié: (2021)

Atypical antipsychotics as add-on treatment in late-life depression
par: Cakir S, et autres
Publié: (2016)

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
par: Hýža M, et autres
Publié: (2021)

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
par: de Bartolomeis A, et autres
Publié: (2016)

Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
par: Chih-Sung Liang, et autres
Publié: (2021)

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
par: Such P, et autres
Publié: (2021)

The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice
par: Li F, et autres
Publié: (2019)

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
par: Salzman PM, et autres
Publié: (2017)

Long-acting injectable antipsychotics: focus on olanzapine pamoate
par: JP Lindenmayer
Publié: (2010)

Description of a Feline Injection-Site Fibrosarcoma with Metastasis in the Cerebellum
par: Cora Roxana, et autres
Publié: (2017)

Assessment of Antipsychotic Medications on Social Media: Machine Learning Study
par: Miguel A. Alvarez-Mon, et autres
Publié: (2021)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
par: Leonid Mikhaylovich Bardenshteyn, et autres
Publié: (2010)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
par: Rachael K. Blackman, et autres
Publié: (2022)

The Youth and Childhood Adversity Scale: a step towards developing a new measure of adversity and its severity
par: Pascal Schlechter, et autres
Publié: (2021)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
par: Citrome L, et autres
Publié: (2021)

Use of atypical antipsychotics in the elderly: a clinical review
par: Gareri P, et autres
Publié: (2014)

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
par: Dhiren Singh, et autres
Publié: (2009)

Antipsychotics and risk of natural death in patients with schizophrenia
par: Chen Y, et autres
Publié: (2019)

Large-Eddy Simulation of Laser-Ignited Direct Injection Gasoline Spray for Emission Control
par: Fabien Tagliante, et autres
Publié: (2021)

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
par: Brasso C, et autres
Publié: (2017)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
par: Ping Yin, et autres
Publié: (2021)

The efficacy of antipsychotics for prolonged delirium with renal dysfunction
par: Asano S, et autres
Publié: (2017)

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life
par: Cuomo I, et autres
Publié: (2018)

Effects of soil cultivation, fertilisation, initial seedling diameter and plant handling on the development of maturing Pinus radiata D. Don on Kaingaroa gravelly sand in the Central North Island of New Zealand
par: MASON,EUAN G
Publié: (2004)

Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study
par: Kiwan N, et autres
Publié: (2019)

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
par: Dayabandara M, et autres
Publié: (2017)

Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
par: Natalia N. Petrova, et autres
Publié: (2020)